A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion
Journal of Neuromuscular Diseases · 2023
DOI: 10.3233/jnd-221669 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Neuromuscular Diseases, 2023. Verfasst von Yoshiaki Takahashi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kagawa Prefectural Central Hospital, Kagawa, Japan. Hauptthemen laut MEDLINE: Muscular Dystrophy, Oculopharyngeal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Immediately after the initial methionine codon, the PABPN1 gene encodes a stretch of 10 alanines, 1 glycine, and 2 alanines. Oculopharyngeal muscular dystrophy (OPMD) is caused by the expansion of the first 10 alanine stretches. The only exception is the missense mutation of glycine at the 12th residue into alanine, which elongates the stretch to 13 alanines by connecting the first and second stretch with the addition of one alanine in between, indicating that the expansion or elongation of the alanine stretch results in OPMD. We report a 77-year-old man with the novel missense mutation c.34G > T (p.Gly12Trp) in PABPN1 gene whose clinicopathological findings were compatible with OPMD. He presented with slowly progressive bilateral ptosis, dysphagia, and symmetrical proximal dominant muscle weakness. Magnetic resonance imaging revealed selective fat replacement of the tongue, bilateral adductor magnus, and soleus muscles. Immunohistochemistry studies of the muscle biopsy sample revealed PABPN1-posibive aggregates in the myonuclei which have been reported to be specific to OPMD. This is the first OPMD case caused by neither the expansion nor the elongation of alanine stretch. The present case suggests that OPMD may be caused not only by triplet repeats but also by point mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Kagawa Prefectural Central Hospital, Kagawa, Japan.
- Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Zitieren
APA
Takahashi, Y., Morimoto, N., Nada, T., Morimoto, M., Eura, N., Minami, N., & Nishino, I. (2023). A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-221669
Vancouver
Takahashi Y, Morimoto N, Nada T, Morimoto M, Eura N, Minami N, et al. A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion. Journal of Neuromuscular Diseases. 2023. doi:10.3233/jnd-221669
BibTeX
@article{Takahashi2023,
author = {Takahashi, Yoshiaki and Morimoto, Nobutoshi and Nada, Tomoaki and Morimoto, Mizuki and Eura, Nobuyuki and Minami, Narihiro and Nishino, Ichizo},
title = {A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion},
journal = {Journal of Neuromuscular Diseases},
year = {2023},
doi = {10.3233/jnd-221669}
}
EUVIMED